Cargando…
Inhibition of lung tumorigenesis by a small molecule CA170 targeting the immune checkpoint protein VISTA
Expressed on cells of the myeloid and lymphoid lineages, V-domain Ig Suppressor of T cell Activation (VISTA) is an emerging target for cancer immunotherapy. Blocking VISTA activates both innate and adaptive immunity to eradicate tumors in mice. Using a tripeptide small molecule antagonist of VISTA C...
Autores principales: | Pan, Jing, Chen, Yao, Zhang, Qi, Khatun, Achia, Palen, Katie, Xin, Gang, Wang, Li, Yang, Chuanjia, Johnson, Bryon D., Myers, Charles R., Sei, Shizuko, Shoemaker, Robert H., Lubet, Ronald A., Wang, Yian, Cui, Weiguo, You, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302676/ https://www.ncbi.nlm.nih.gov/pubmed/34302042 http://dx.doi.org/10.1038/s42003-021-02381-x |
Ejemplares similares
-
Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
por: Pan, Jing, et al.
Publicado: (2023) -
Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator
por: Pan, Jing, et al.
Publicado: (2019) -
Striking efficacy of a vaccine targeting TOP2A for triple-negative breast cancer immunoprevention
por: Lee, Sang Beom, et al.
Publicado: (2023) -
Immunoprevention of KRAS-driven lung adenocarcinoma by a multipeptide vaccine
por: Pan, Jing, et al.
Publicado: (2017) -
Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR‐Driven Lung Cancer
por: Huang, Mofei, et al.
Publicado: (2022)